Skip to main content
    A

    Artivion Inc (AORT)

    Official site

    HEALTHCARE • MEDICAL DEVICES • NYSE

    $18.46
    -0.64 (-3.35%)

    Market Cap: $931.88M

    Last updated: Nov 17, 2026 at 11:04 AM ET

    Artivion Inc (AORT) P/E Ratio & Valuation History

    Updated Nov 17, 2026. Multiples are computed from end-of-day prices, company filings and consensus analyst estimates.

    Artivion (AORT) trades at 40.1x trailing earnings and 1.9x sales. Its P/E of 40.1x is below its 10-year median of 86.3x. Its forward P/E is 46.1x. The median P/E across 6 similar companies is 13.2x.

    Current Multiples

    Its forward P/E is above its trailing P/E, which implies earnings per share about 13.0% lower over the next year. PEG is left out because the growth rate behind it, P/E divided by PEG, is under 2% a year.

    MultipleValue
    P/E (trailing)40.1x
    Forward P/E46.1x
    Price to sales1.9x
    Price to book2.0x
    EV/EBITDA27.8x
    PEGN/A
    FCF yield-4.9%
    As of Nov 17, 2026

    Historical Medians

    Against its 10-year medians, its P/S is 40.6% below 3.2x and its P/B is 33.3% below 3.0x.

    MultipleCurrent5-year median10-year median
    P/E40.1xN/A86.3x
    P/S1.9x2.5x3.2x
    P/B2.0x2.8x3.0x
    Medians of month-end values through Oct 2026: 60 months (5-year) and 99 to 120 months (10-year).

    Valuation History

    Over the 8 of the 10 year ends shown that have a P/E, its P/E ranged from 39.9x in 2016 to 242.4x in 2022.

    Year endPriceP/EP/SP/B
    2025$45.6172.4x4.7x5.0x
    2024$28.59N/A3.1x4.3x
    2023$17.8885.1x2.1x2.6x
    2022$12.12242.4x1.5x1.7x
    2021$20.35N/A2.7x2.6x
    2020$23.61102.7x3.5x2.8x
    2019$27.0987.4x3.6x3.5x
    2018$28.38113.5x3.9x3.8x
    2017$19.1547.9x3.3x2.3x
    2016$19.1539.9x3.4x3.1x
    Each year's multiples use the split-adjusted closing price of that year's last trading day over trailing per-share results as reported; periods with losses are left out.

    GNG Valuation

    GNG viewUndervalued

    GNG fair value is part of GNG Pro. See plans

    Frequently Asked Questions About AORT

    What is AORT's forward P/E ratio?

    Artivion has a forward P/E ratio of 46.1x.

    Is AORT stock overvalued?

    GNG's valuation label for AORT is Undervalued. Its P/E of 40.1x compares with a median of 13.2x across 6 similar companies.

    What is AORT's price to sales ratio?

    Artivion has a price to sales ratio of 1.9x.

    What is Artivion's average P/E ratio over 10 years?

    Artivion's median P/E over the last 10 years is 86.3x, from 99 month-end values through Oct 2026.